Seasonal Influenza Vaccines Market Set To Take Off For Significant Growth Said by Global Key Venders Sanofi S.A., CSL Limited, GlaxoSmithKline Plc., and Medimmune, LLC.

Influenza is contagious respiratory disease that is caused by influenza viruses and can lead to hospitalization and even death in certain severe cases. Influenza virus infect the respiratory tract (nose, throat, and lungs) in humans. Seasonal influenza detected year-round and the virus is most common during the influenza season especially in fall and winter months. Moreover, the exact timing and duration of influenza season varies, however influenza activity often begins in winter months. At various geographical regions, influenza infection exist at a low level throughout the year, however its shows seasonal increase typically during the winter months. A seasonal influenza flu vaccine aids in reducing the risk of getting infected with seasonal flu and prevent its spreading throughout the year.

Download PDF Brochure of Market Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1604

The 2017–2018 recommendations by the Advisory Committee on Immunization Practices (ACIP) mentions routine annual influenza vaccination for everyone aged 6 months and older with either inactivated influenza vaccine (IIV) or recombinant influenza vaccine (RIV). A high variability and broad host specificity of influenza viruses are the major causes of repeated influenza infections. Moreover, virus neutralizing antibodies induced by various vaccines are strain specific, which leads to vaccinations being updated each year. To tackle this issue, various government and private research organizations are engaged in developing novel vaccines to increase efficacy of these vaccines.

Seasonal Influenza Vaccines Market – Drivers

Increasing incidence of seasonal influenza infection in various geographies is expected to be a major driving factor for growth of global seasonal influenza vaccines market. Rising pandemic events of influenza virus and their severity attributed to the genetic diversity of influenza virus is also another factor aiding in growth of the market. According to the World Health Organization (WHO), 2015, around 233 million outpatient visits, 5.2 million hospital admissions, and 7.4 million deaths are expected if a pandemic case were to occur, globally. Also, the Centers for Medicare & Medicaid Services (CMS) provides reimbursement covering 100% of the costs of one seasonal influenza virus vaccinations per influenza season, and it also covers the seasonal influenza virus vaccinations. Thus, favorable reimbursement is also expected to positively affect adoption rates of seasonal influenza vaccines, thus propelling the market growth.

In addition to this, according to the Indian Journal of Medical Research, June 2016, the influenza A (H1N1) pdm09 outbreak in India caused 30,000 laboratory confirmed cases with over 1,700 deaths from 2009 to 2015. The World Health Organization (WHO): GISRS (Global Influenza Surveillance and Response System) laboratories from 2 April 2018 to 15 April 2018; tested over 137,071 specimens from various National Influenza centers (NIC) and other national influenza laboratories of 113 countries. Among these collected specimens, 21,639 were positive for influenza viruses, including 12,034 (55.6%) were typed as influenza A and 9,605 (44.4%) as influenza B. According to the data published in European Centre for Disease Prevention and Control (ECDC), in February 2018, around 44,000 people die annually of respiratory diseases associated with seasonal influenza in the European Region, out of a total of up to 6, 50, 000 global deaths, annually.

Request For Customization of Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1604

Seasonal Influenza Vaccines Market – Competitor

Some of the key players in the seasonal influenza vaccines market includes Sanofi S.A., CSL Limited, GlaxoSmithKline Plc., and Medimmune, LLC. Key players in the market are involved in strategic mergers and acquisitions, to cater to increasing demand for these vaccines.

Seasonal Influenza Vaccines Market – Taxonomy

By Vaccine Type:

Trivalent flu vaccines
Quadrivalent flu vaccines

By Virus Type:

Influenza Virus Type A
Influenza Virus Type B

By Geography:
North America
Europe
Asia Pacific
Middle East
Latin America
Africa

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.